Evidence map›Paper›PMID 33033006›Full record

ArticleBMJ open2020

Can extranodal tumour deposits be diagnosed on MRI? Protocol for a multicentre clinical trial (the COMET trial).

Amy C Lord, Brendan Moran, Muti Abulafi, Shahnawaz Rasheed, Iris D Nagtegaal, Monica Terlizzo, Gina Brown

Registry-linked trialAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03303547 (Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03303547 narecruitingnot on this map

Concordance of Imaging and Pathology Diagnosis of Extranodal Tumour Deposits

TypeinterventionalSponsorImperial College LondonRan2017 to 2031Enrolled200ConditionsAdenocarcinoma of the RectumArmsMRI mapping to guide pathological sampling of extranodal tumour deposits
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Observational
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amy C LordDepartment of General Surgery, Royal Marsden NHS Foundation Trust, London, UK amylord@nhs.net.ORCID 0000-0001-5579-6171
Brendan MoranDepartment of General Surgery, Basingstoke and North Hampshire NHS Foundation Trust, Basingstoke, UK.
Muti AbulafiDepartment of General Surgery, Croydon University Hospital, Croydon, UK.
Shahnawaz RasheedDepartment of General Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Iris D NagtegaalDepartment of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Monica TerlizzoDepartment of General Surgery, Royal Marsden NHS Foundation Trust, London, UK.
Gina BrownDepartment of Radiology, Royal Marsden NHS Foundation Trust, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionTumour deposits (TDs) are a poor prognostic marker when seen on pathology, and are worse than lymph node metastases (LNMs). They are now being reported on MRI as discontinuous nodules of extramural venous invasion but this diagnosis has not been validated and it is unclear how it correlates with the diagnosis of TDs on pathology. METHODS AND ANALYSIS: This is a prospective interventional clinical trial which aims to directly map the location of TDs on MRI and correlate what is seen on MRI with the pathology findings at each location. All patients with rectal cancer undergoing resectional surgery are eligible (including those undergoing preoperative therapy). The primary outcome is the prevalence of TDs seen on pathology. Secondary outcomes are to assess radiological and pathological interobserver agreement, assess the effect of TDs on prognosis and carry out exploratory work looking at differences between TDs and LNMs. The estimated sample size is 100 to detect a twofold increase in the pathological diagnosis of TD when MRI mapping is used. ETHICS AND DISSEMINATION: Ethical approval has been granted from the South Central-Hampshire B Research and Ethics Committee (IRAS 217627). The study will be carried out under standard operative procedures within the Royal Marsden Hospital. TRIAL REGISTRATION NUMBER: NCT03303547.

Indexed as

Extranodal ExtensionRectal NeoplasmsHumansMagnetic Resonance ImagingMulticenter Studies as TopicNeoplasm StagingProspective Studiescolorectal surgerygastrointestinal imaginggastrointestinal tumoursmagnetic resonance imagingsurgical pathology

Identifiers

PMID33033006
PMCPMC7542933

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.